Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172525 | SCV000050857 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000039414 | SCV000063098 | uncertain significance | not specified | 2015-12-10 | criteria provided, single submitter | clinical testing | The p.Gln638His variant in DSC2 has been reported in at least 4 individuals with a range of phenotypes (DCM, ARVD/C, HCM) (Elliot 2010, Cox 2011, LMM unpublishe d data). This variant has been identified in 0.1% (11/16342) of South Asian chr omosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org; db SNP rs147742157) and once in another control population in the literature (Den H aan 2009). Computational prediction tools and conservation analysis suggest that the p.Gln638His variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical signif icance of the p.Gln638His variant is uncertain. |
Gene |
RCV000172525 | SCV000233435 | likely benign | not provided | 2020-11-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21606396, 23861362, 20031617, 20716751, 20152563, 20857253, 20829228) |
Invitae | RCV001081432 | SCV000551493 | benign | Arrhythmogenic right ventricular dysplasia 11 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000172525 | SCV000704878 | uncertain significance | not provided | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000776094 | SCV000910885 | benign | Cardiomyopathy | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852737 | SCV000995452 | likely benign | Hypertrophic cardiomyopathy | 2018-03-12 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001081432 | SCV001288105 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2018-02-05 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
CHEO Genetics Diagnostic Laboratory, |
RCV000776094 | SCV001334025 | benign | Cardiomyopathy | 2017-11-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039414 | SCV001363402 | benign | not specified | 2020-08-17 | criteria provided, single submitter | clinical testing | Variant summary: DSC2 c.1914G>C (p.Gln638His) results in a non-conservative amino acid change located in the Cadherin-like domain (IPR002126) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00054 in 252554 control chromosomes, predominantly at a frequency of 0.00069 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 28 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSC2 causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.1914G>C has been reported in the literature in individuals affected with Dilated Cardiomyopathy (DCM) and Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC, Elliott_2010, Xu_2010). These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (likely benign/benign, n=5). Based on the evidence outlined above, the variant was re-classified as benign. |
Ce |
RCV000172525 | SCV002063676 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | DSC2: BP4 |
Ambry Genetics | RCV002408524 | SCV002720005 | likely benign | Cardiovascular phenotype | 2018-05-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003934941 | SCV004752280 | likely benign | DSC2-related disorder | 2023-04-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000172525 | SCV001924264 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000172525 | SCV001930070 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000172525 | SCV001951362 | likely benign | not provided | no assertion criteria provided | clinical testing |